Evaxion Biotech

CUSIP 29970R204COMEVAXUSDQ4 2025

Evaxion Biotech — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

20.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Feb 3, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 3, 2025	Merck &Amp; Co., Inc.	13G/A	20.0%	63.00M	SEC
2	Nov 14, 2024	Armistice Capital, LLC	13G	10.0%	555.3K	SEC
3	Nov 6, 2024	Merck & Co., Inc.	13G/A	12.9%	7.72M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Merck & Co., Inc.	1.21M	$5.79M